Tempest Therapeutics special meeting adjourned after proposal fell short of 75% vote threshold
TPST•Special meeting on charter amendment adjourned
Tempest Therapeutics held a reconvened special shareholder meeting on Sept. 15, 2026 to vote on a charter amendment.
The amendment would remove specified supermajority voting requirements and permit shareholder action by written consent.
Shareholders did not approve the amendment at the meeting, leaving the charter unchanged.
The meeting was adjourned and is set to reconvene on Oct. 14, 2026 for another vote on the same amendment.
